Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.44 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 41.92.
Market Cap
8.44T
Revenue
4.52T
Profits
201.27B
PE Ratio
41.92
Profit Margin
4.45%
Dividend Yield
0.43%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 825.47B | -0.76% | 2,360,165 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 578.31B | 0.90% | 10,317,849 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 371.90B | 1.84% | 6,199,003 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 313.96B | 1.06% | 2,257,640 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 296.29B | -0.16% | 12,448,883 | 65.01B |
| 6 | NVS | Novartis AG | 294.01B | -0.71% | 1,260,268 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 285.18B | 0.38% | 5,899,379 | 447.57B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 195.93B | 2.53% | 2,572,061 | 44.56B |
| 9 | AMGN | Amgen Inc. | 189.40B | 0.32% | 2,104,259 | 36.75B |
| 10 | ABT | Abbott Laboratories | 175.99B | 0.36% | 11,689,909 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 174.33B | 1.02% | 6,473,261 | 29.44B |
| 12 | NVO | Novo Nordisk A/S | 172.41B | 3.53% | 20,010,798 | 48.59B |
| 13 | ISRG | Intuitive Surgical, Inc. | 165.94B | 1.80% | 1,973,198 | 10.06B |
| 14 | PFE | Pfizer Inc. | 154.21B | -0.84% | 24,557,572 | 62.58B |
| 15 | DHR | Danaher Corporation | 140.56B | 1.40% | 3,336,401 | 24.57B |
| 16 | SYK | Stryker Corporation | 132.47B | -0.39% | 2,305,059 | 25.12B |
| 17 | GSK | GSK plc | 118.71B | 0.41% | 3,769,384 | 43.97B |
| 18 | BMY | Bristol-Myers Squibb Company | 118.58B | 0.03% | 7,612,921 | 48.19B |
| 19 | SNY | Sanofi | 115.44B | 1.45% | 2,069,643 | 54.85B |
| 20 | MDT | Medtronic plc | 113.14B | 0.14% | 5,640,177 | 35.48B |
| 21 | VRTX | Vertex Pharmaceuticals Incorporated | 113.01B | 0.96% | 1,445,357 | 12.00B |
| 22 | HCA | HCA Healthcare, Inc. | 111.48B | 0.25% | 752,618 | 75.60B |
| 23 | MCK | McKesson Corporation | 105.68B | -0.21% | 614,277 | 397.96B |
| 24 | CVS | CVS Health Corporation | 99.48B | -0.60% | 6,105,008 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 94.85B | 1.01% | 12,354,184 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 77.53B | 1.21% | 637,726 | 14.34B |
| 27 | CI | The Cigna Group | 71.87B | -0.92% | 939,521 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 68.83B | -0.86% | 1,687,140 | 199.13B |
| 29 | MDLN | Medline Inc. | 62.62B | 0.95% | 4,459,127 | 28.43B |
| 30 | COR | Cencora, Inc. | 62.23B | 0.24% | 1,082,128 | 325.78B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 55.75B | 0.17% | 3,180,730 | 28.48B |
| 32 | ARGX | argenx SE | 51.73B | 2.36% | 228,269 | 4.24B |
| 33 | ZTS | Zoetis Inc. | 50.93B | 0.86% | 2,778,817 | 9.47B |
| 34 | CAH | Cardinal Health, Inc. | 50.58B | 0.36% | 1,407,193 | 244.67B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 46.39B | 1.75% | 455,045 | 4.30B |
| 36 | EW | Edwards Lifesciences Corporation | 45.09B | 0.10% | 5,859,511 | 6.07B |
| 37 | ALNY | Alnylam Pharmaceuticals, Inc. | 45.01B | 1.92% | 1,228,638 | 3.71B |
| 38 | BDX | Becton, Dickinson and Company | 44.34B | 0.19% | 2,888,273 | 21.92B |
| 39 | HLN | Haleon plc | 43.21B | -1.32% | 4,552,944 | 14.85B |
| 40 | ALC | Alcon Inc. | 39.36B | 0.25% | 1,830,155 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 36.99B | 1.99% | 4,292,402 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 34.38B | 1.43% | 316,748 | 5.34B |
| 43 | GEHC | GE HealthCare Technologies Inc. | 34.07B | 1.14% | 2,179,153 | 20.63B |
| 44 | A | Agilent Technologies, Inc. | 34.02B | 2.46% | 2,676,723 | 7.07B |
| 45 | RMD | ResMed Inc. | 33.46B | 0.19% | 646,334 | 5.40B |
| 46 | INSM | Insmed Incorporated | 33.11B | 1.50% | 1,309,472 | 606.42M |
| 47 | WAT | Waters Corporation | 32.49B | 1.94% | 749,676 | 3.17B |
| 48 | NTRA | Natera, Inc. | 30.42B | 6.31% | 1,731,706 | 2.31B |
| 49 | IQV | IQVIA Holdings Inc. | 29.42B | 1.91% | 1,238,103 | 16.31B |
| 50 | RVMD | Revolution Medicines, Inc. | 29.13B | 7.86% | 8,202,162 | - |
| 51 | RPRX | Royalty Pharma plc | 28.16B | 0.81% | 3,887,146 | 2.38B |
| 52 | PHG | Koninklijke Philips N.V. | 27.79B | 1.89% | 605,311 | 20.94B |
| 53 | MTD | Mettler-Toledo International Inc. | 27.16B | -0.32% | 173,505 | 4.03B |
| 54 | BIIB | Biogen Inc. | 26.26B | 1.47% | 1,550,545 | 9.89B |
| 55 | VEEV | Veeva Systems Inc. | 25.98B | 0.40% | 2,267,836 | 3.20B |
| 56 | UTHR | United Therapeutics Corporation | 25.36B | 0.16% | 440,811 | 3.18B |
| 57 | BNTX | BioNTech SE | 24.89B | 1.77% | 1,114,434 | 3.37B |
| 58 | DXCM | DexCom, Inc. | 24.23B | -0.27% | 4,730,258 | 4.66B |
| 59 | HUM | Humana Inc. | 23.56B | -1.02% | 1,123,457 | 129.66B |
| 60 | LH | Labcorp Holdings Inc. | 22.10B | 1.78% | 572,065 | 13.95B |
| 61 | STE | STERIS plc | 22.05B | -0.01% | 639,969 | 5.83B |
| 62 | DGX | Quest Diagnostics Incorporated | 21.49B | 0.65% | 885,488 | 11.04B |
| 63 | MRNA | Moderna, Inc. | 20.96B | 4.26% | 5,355,308 | 1.94B |
| 64 | ROIV | Roivant Sciences Ltd. | 20.84B | 0.59% | 3,954,340 | 13.31M |
| 65 | ILMN | Illumina, Inc. | 19.93B | 2.65% | 1,195,080 | 4.34B |
| 66 | INCY | Incyte Corporation | 19.44B | 2.24% | 1,519,827 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 19.30B | 3.07% | 785,790 | 3.07B |
| 68 | ZBH | Zimmer Biomet Holdings, Inc. | 18.68B | 1.24% | 2,652,579 | 8.23B |
| 69 | CNC | Centene Corporation | 18.32B | -0.56% | 3,016,357 | 176.15B |
| 70 | GMAB | Genmab A/S | 17.86B | 3.05% | 1,938,445 | 3.72B |
| 71 | THC | Tenet Healthcare Corporation | 17.10B | 1.87% | 983,721 | 21.31B |
| 72 | VTRS | Viatris Inc. | 16.20B | 0.58% | 6,433,924 | 14.30B |
| 73 | SMMT | Summit Therapeutics Inc. | 16.17B | 4.09% | 2,322,728 | - |
| 74 | ASND | Ascendis Pharma A/S | 15.44B | 0.52% | 515,158 | 845.52M |
| 75 | BBIO | BridgeBio Pharma, Inc. | 15.11B | 0.08% | 2,246,832 | 502.08M |
| 76 | RGC | Regencell Bioscience Holdings Limited | 14.89B | -6.61% | 145,893 | - |
| 77 | MEDP | Medpace Holdings, Inc. | 14.85B | 3.74% | 326,093 | 2.53B |
| 78 | SNN | Smith & Nephew plc | 14.64B | 1.03% | 610,316 | 6.16B |
| 79 | COO | The Cooper Companies, Inc. | 13.97B | -0.13% | 1,670,916 | 4.15B |
| 80 | PODD | Insulet Corporation | 13.96B | 1.86% | 733,391 | 2.71B |
| 81 | ALGN | Align Technology, Inc. | 13.23B | 2.23% | 879,275 | 4.03B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.13B | 3.55% | 1,112,121 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 13.06B | 0.21% | 255,338 | 1.40B |
| 84 | GMED | Globus Medical, Inc. | 12.84B | 2.11% | 1,184,213 | 2.94B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.68B | 2.41% | 1,595,178 | 943.71M |
| 86 | FMS | Fresenius Medical Care AG | 12.62B | -2.15% | 1,034,377 | 23.05B |
| 87 | JAZZ | Jazz Pharmaceuticals plc | 12.38B | 2.94% | 1,071,077 | 4.27B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.04B | -0.13% | 302,687 | 958.40M |
| 89 | ELAN | Elanco Animal Health Incorporated | 12.04B | 1.05% | 2,611,516 | 4.72B |
| 90 | SOLV | Solventum Corporation | 11.97B | 2.39% | 1,418,025 | 8.33B |
| 91 | EXEL | Exelixis, Inc. | 11.91B | 2.00% | 2,533,407 | 2.32B |
| 92 | ENSG | The Ensign Group, Inc. | 11.59B | -0.92% | 256,130 | 5.06B |
| 93 | GH | Guardant Health, Inc. | 11.33B | 5.10% | 1,972,649 | 982.02M |
| 94 | UHS | Universal Health Services, Inc. | 11.10B | -0.68% | 499,083 | 17.36B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 10.98B | -1.06% | 2,228,924 | 3.85B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.67B | 1.08% | 1,596,840 | 3.22B |
| 97 | EHC | Encompass Health Corporation | 10.61B | -0.80% | 718,999 | 5.94B |
| 98 | RVTY | Revvity, Inc. | 10.45B | 0.94% | 600,682 | 2.86B |
| 99 | DVA | DaVita Inc. | 9.98B | -1.39% | 448,959 | 13.64B |
| 100 | ABVX | ABIVAX Société Anonyme | 9.88B | 3.70% | 1,050,526 | 5.37M |
| 101 | PRAX | Praxis Precision Medicines, Inc. | 9.57B | 8.39% | 703,317 | 7.46M |
| 102 | AXSM | Axsome Therapeutics, Inc. | 9.42B | 3.28% | 820,744 | 638.50M |
| 103 | BTSG | BrightSpring Health Services, Inc. | 9.40B | 0.02% | 1,258,239 | 12.91B |
| 104 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.34B | 4.55% | 1,467,260 | 1.09B |
| 105 | MASI | Masimo Corporation | 9.31B | -0.04% | 505,196 | 1.53B |
| 106 | TECH | Bio-Techne Corporation | 9.18B | 1.96% | 2,543,579 | 1.22B |
| 107 | BAX | Baxter International Inc. | 9.08B | -0.23% | 5,761,226 | 11.24B |
| 108 | PCVX | Vaxcyte, Inc. | 9.03B | 1.64% | 1,005,812 | - |
| 109 | TEM | Tempus AI, Inc. | 8.88B | 7.72% | 6,546,503 | 1.27B |
| 110 | HSIC | Henry Schein, Inc. | 8.86B | 1.59% | 814,581 | 13.18B |
| 111 | CRL | Charles River Laboratories International, Inc. | 8.83B | 0.54% | 875,438 | 4.02B |
| 112 | QGEN | Qiagen N.V. | 8.64B | -0.36% | 1,427,106 | 2.09B |
| 113 | ICLR | ICON Public Limited Company | 8.63B | 2.44% | 899,379 | 8.10B |
| 114 | ATR | AptarGroup, Inc. | 8.35B | -0.83% | 315,550 | 3.78B |
| 115 | NUVL | Nuvalent, Inc. | 8.26B | 1.30% | 434,837 | - |
| 116 | CYTK | Cytokinetics, Incorporated | 8.17B | -0.55% | 1,897,124 | 88.04M |
| 117 | HALO | Halozyme Therapeutics, Inc. | 7.97B | 0.49% | 1,459,941 | 1.40B |
| 118 | KRYS | Krystal Biotech, Inc. | 7.95B | 0.97% | 389,160 | 389.13M |
| 119 | BIO | Bio-Rad Laboratories, Inc. | 7.89B | 1.41% | 200,337 | 2.58B |
| 120 | IBRX | ImmunityBio, Inc. | 7.85B | 4.11% | 15,645,827 | 113.29M |
| 121 | MOH | Molina Healthcare, Inc. | 7.68B | -1.65% | 673,212 | 43.56B |
| 122 | RGEN | Repligen Corporation | 7.39B | 6.88% | 1,221,982 | 738.26M |
| 123 | KYMR | Kymera Therapeutics, Inc. | 7.34B | 1.51% | 573,053 | 39.21M |
| 124 | GKOS | Glaukos Corporation | 7.00B | 0.86% | 579,118 | 507.44M |
| 125 | GRFS | Grifols, S.A. | 6.91B | 1.85% | 708,227 | 8.83B |
| 126 | HQY | HealthEquity, Inc. | 6.87B | 1.81% | 1,392,923 | 1.31B |
| 127 | BLTE | Belite Bio, Inc | 6.76B | -1.03% | 115,947 | - |
| 128 | ACLX | Arcellx, Inc. | 6.74B | 0.02% | 543,076 | 22.29M |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.68B | 7.33% | 849,447 | 46.02M |
| 130 | APGE | Apogee Therapeutics, Inc. | 6.53B | 1.99% | 559,686 | - |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.12B | 0.06% | 6,226,107 | 15.00M |
| 132 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | 0.12% | 3,860,332 | - |
| 133 | BRKR | Bruker Corporation | 6.07B | 2.18% | 1,954,841 | 3.44B |
| 134 | PTCT | PTC Therapeutics, Inc. | 6.04B | 3.68% | 1,400,652 | 1.73B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.96B | 0.54% | 520,405 | 189.76M |
| 136 | BLCO | Bausch + Lomb Corporation | 5.92B | 0.54% | 236,552 | 5.10B |
| 137 | COGT | Cogent Biosciences, Inc. | 5.88B | -0.08% | 2,338,923 | - |
| 138 | MIRM | Mirum Pharmaceuticals, Inc. | 5.85B | 0.42% | 894,516 | 521.31M |
| 139 | CELC | Celcuity Inc. | 5.84B | 0.37% | 673,606 | - |
| 140 | CAI | Caris Life Sciences, Inc. | 5.71B | 5.54% | 2,006,888 | 812.03M |
| 141 | SRRK | Scholar Rock Holding Corporation | 5.69B | 0.06% | 1,754,295 | - |
| 142 | CGON | CG Oncology, Inc. | 5.68B | -0.62% | 2,010,063 | 4.04M |
| 143 | XENE | Xenon Pharmaceuticals Inc. | 5.66B | 1.28% | 851,666 | 7.50M |
| 144 | ALKS | Alkermes plc | 5.63B | 0.36% | 1,837,491 | 1.48B |
| 145 | ERAS | Erasca, Inc. | 5.55B | 9.44% | 5,467,098 | - |
| 146 | AVTR | Avantor, Inc. | 5.54B | 0.24% | 6,271,004 | 6.55B |
| 147 | TFX | Teleflex Incorporated | 5.53B | 1.65% | 823,921 | 1.99B |
| 148 | CRSP | CRISPR Therapeutics AG | 5.46B | 3.70% | 2,100,126 | 3.51M |
| 149 | IMVT | Immunovant, Inc. | 5.40B | 5.69% | 2,314,415 | - |
| 150 | LNTH | Lantheus Holdings, Inc. | 5.38B | 1.31% | 603,495 | 1.54B |
| 151 | APLS | Apellis Pharmaceuticals, Inc. | 5.22B | 0.02% | 4,524,967 | 1.00B |
| 152 | PACS | PACS Group, Inc. | 5.21B | -2.21% | 766,220 | 5.29B |
| 153 | CHE | Chemed Corporation | 5.18B | -2.89% | 186,851 | 2.53B |
| 154 | TGTX | TG Therapeutics, Inc. | 5.10B | 2.28% | 1,412,787 | 616.29M |
| 155 | SYRE | Spyre Therapeutics, Inc. | 5.03B | 1.17% | 1,672,982 | - |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 5.02B | 5.46% | 1,140,607 | 2.04M |
| 157 | HIMS | Hims & Hers Health, Inc. | 4.87B | 0.99% | 19,377,312 | 2.35B |
| 158 | CORT | Corcept Therapeutics Incorporated | 4.65B | 0.88% | 811,160 | 761.41M |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 4.63B | 8.85% | 570,598 | 268.09M |
| 160 | OSCR | Oscar Health, Inc. | 4.55B | -1.23% | 5,758,654 | 11.70B |
| 161 | SHC | Sotera Health Company | 4.54B | 1.46% | 1,965,127 | 1.16B |
| 162 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 4,451,877 | 634.21M |
| 163 | RDNT | RadNet, Inc. | 4.48B | 2.72% | 564,569 | 2.04B |
| 164 | NVST | Envista Holdings Corporation | 4.46B | 1.75% | 1,100,833 | 2.72B |
| 165 | OPCH | Option Care Health, Inc. | 4.38B | -3.56% | 1,732,465 | 5.65B |
| 166 | ALHC | Alignment Healthcare, Inc. | 4.35B | 1.43% | 1,991,194 | 3.95B |
| 167 | WAY | Waystar Holding Corp. | 4.30B | 1.22% | 2,173,276 | 1.10B |
| 168 | MMED | MiniMed Group, Inc. | 4.27B | 5.66% | 1,080,114 | 2.89B |
| 169 | MMSI | Merit Medical Systems, Inc. | 4.19B | -0.04% | 583,343 | 1.52B |
| 170 | AMRX | Amneal Pharmaceuticals, Inc. | 4.19B | 2.26% | 1,056,531 | 3.02B |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.16B | 2.82% | 710,262 | 7.70M |
| 172 | VKTX | Viking Therapeutics, Inc. | 4.12B | 1.46% | 2,150,279 | - |
| 173 | DOCS | Doximity, Inc. | 4.11B | -1.81% | 2,237,284 | 637.78M |
| 174 | STVN | Stevanato Group S.p.A. | 4.03B | 6.95% | 1,269,666 | 1.39B |
| 175 | IRTC | iRhythm Holdings, Inc. | 3.98B | 2.31% | 475,832 | 747.14M |
| 176 | TMDX | TransMedics Group, Inc. | 3.97B | 2.05% | 479,096 | 605.49M |
| 177 | NAMS | NewAmsterdam Pharma Company N.V. | 3.96B | -4.99% | 1,620,327 | 22.50M |
| 178 | TVTX | Travere Therapeutics, Inc. | 3.89B | 37.23% | 14,944,942 | 490.73M |
| 179 | BLLN | BillionToOne, Inc. | 3.81B | 5.20% | 401,532 | 305.11M |
| 180 | GPCR | Structure Therapeutics Inc. | 3.77B | -1.90% | 1,050,169 | - |
| 181 | ACAD | ACADIA Pharmaceuticals Inc. | 3.75B | 2.61% | 1,972,975 | 1.07B |
| 182 | TLX | Telix Pharmaceuticals Limited | 3.74B | -4.80% | 547,263 | 803.79M |
| 183 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.59B | -0.80% | 727,241 | 677.56M |
| 184 | EWTX | Edgewise Therapeutics, Inc. | 3.56B | -2.01% | 1,069,758 | - |
| 185 | LIVN | LivaNova PLC | 3.55B | 0.63% | 426,857 | 1.39B |
| 186 | TWST | Twist Bioscience Corporation | 3.52B | 13.95% | 2,954,559 | 391.56M |
| 187 | LEGN | Legend Biotech Corporation | 3.46B | 5.65% | 2,744,699 | 1.03B |
| 188 | TNGX | Tango Therapeutics, Inc. | 3.43B | 11.60% | 3,538,911 | 62.38M |
| 189 | LQDA | Liquidia Corporation | 3.41B | -0.36% | 844,043 | 158.32M |
| 190 | ORKA | Oruka Therapeutics, Inc. | 3.32B | 9.25% | 1,617,512 | - |
| 191 | BKD | Brookdale Senior Living Inc. | 3.31B | 2.35% | 2,935,689 | 3.05B |
| 192 | DYN | Dyne Therapeutics, Inc. | 3.27B | 4.26% | 2,279,825 | - |
| 193 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.20B | 3.35% | 2,196,186 | 588.99M |
| 194 | DNLI | Denali Therapeutics Inc. | 3.20B | 3.81% | 807,082 | - |
| 195 | ICUI | ICU Medical, Inc. | 3.20B | -1.14% | 159,787 | 2.23B |
| 196 | TXG | 10x Genomics, Inc. | 3.17B | 5.17% | 2,838,934 | 642.82M |
| 197 | VERA | Vera Therapeutics, Inc. | 3.17B | 1.49% | 1,249,673 | - |
| 198 | TARS | Tarsus Pharmaceuticals, Inc. | 3.14B | 1.60% | 278,356 | 451.36M |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.11B | 4.02% | 1,611,490 | 376.07M |
| 200 | HNGE | Hinge Health, Inc. | 3.05B | 2.51% | 1,050,816 | 587.86M |
| 201 | ITGR | Integer Holdings Corporation | 3.02B | 1.03% | 276,150 | 1.85B |
| 202 | BEAM | Beam Therapeutics Inc. | 3.01B | 0.40% | 2,191,308 | 139.74M |
| 203 | CON | Concentra Group Holdings Parent, Inc. | 2.92B | 1.56% | 565,380 | 2.16B |
| 204 | ALMS | Alumis Inc. | 2.91B | 1.64% | 1,211,884 | 24.05M |
| 205 | PRVA | Privia Health Group, Inc. | 2.90B | 0.48% | 561,234 | 2.12B |
| 206 | SUPN | Supernus Pharmaceuticals, Inc. | 2.89B | 0.32% | 460,025 | 718.95M |
| 207 | RCUS | Arcus Biosciences, Inc. | 2.88B | 2.77% | 660,418 | 247.00M |
| 208 | IDYA | IDEAYA Biosciences, Inc. | 2.84B | -1.43% | 3,809,355 | 218.71M |
| 209 | WRBY | Warby Parker Inc. | 2.83B | 8.74% | 2,818,591 | 871.91M |
| 210 | HAE | Haemonetics Corporation | 2.81B | 2.04% | 584,979 | 1.32B |
| 211 | MANE | Veradermics, Incorporated | 2.80B | 5.09% | 476,705 | - |
| 212 | KOD | Kodiak Sciences Inc. | 2.78B | 7.44% | 1,344,928 | - |
| 213 | VCYT | Veracyte, Inc. | 2.73B | 5.73% | 504,112 | 517.15M |
| 214 | SLNO | Soleno Therapeutics, Inc. | 2.72B | -0.04% | 4,265,834 | 190.41M |
| 215 | IRON | Disc Medicine, Inc. | 2.69B | 3.01% | 352,773 | - |
| 216 | ELVN | Enliven Therapeutics, Inc. | 2.68B | 2.33% | 771,169 | - |
| 217 | PBH | Prestige Consumer Healthcare Inc. | 2.68B | -0.32% | 439,446 | 1.10B |
| 218 | LMAT | LeMaitre Vascular, Inc. | 2.67B | 1.93% | 336,038 | 249.60M |
| 219 | RLAY | Relay Therapeutics, Inc. | 2.64B | -3.34% | 4,089,894 | 15.36M |
| 220 | CLDX | Celldex Therapeutics, Inc. | 2.62B | 2.27% | 844,239 | 1.55M |
| 221 | IMNM | Immunome, Inc. | 2.59B | 1.24% | 1,290,934 | 6.94M |
| 222 | HCM | HUTCHMED (China) Limited | 2.59B | -0.46% | 27,770 | 548.51M |
| 223 | NHC | National HealthCare Corporation | 2.55B | -3.60% | 93,249 | 1.52B |
| 224 | LFST | LifeStance Health Group, Inc. | 2.54B | 0.77% | 1,323,974 | 1.42B |
| 225 | ADMA | ADMA Biologics, Inc. | 2.50B | 1.06% | 5,821,046 | 510.17M |
| 226 | HTFL | HeartFlow, Inc. | 2.49B | 5.91% | 1,283,539 | 176.03M |
| 227 | ZLAB | Zai Lab Limited | 2.47B | 2.91% | 614,801 | 460.16M |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.44B | 0.04% | 2,410,686 | 3.31B |
| 229 | XRAY | DENTSPLY SIRONA Inc. | 2.44B | 1.66% | 2,984,661 | 3.68B |
| 230 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.43B | 2.76% | 3,711,946 | 874.84M |
| 231 | RARE | Ultragenyx Pharmaceutical Inc. | 2.41B | 3.98% | 1,819,916 | 673.00M |
| 232 | GRDN | Guardian Pharmacy Services, Inc. | 2.39B | -4.30% | 438,439 | 1.45B |
| 233 | PAHC | Phibro Animal Health Corporation | 2.39B | -0.94% | 231,527 | 1.46B |
| 234 | AAPG | Ascentage Pharma Group International | 2.33B | 0.94% | 861 | 82.08M |
| 235 | NKTR | Nektar Therapeutics | 2.33B | 1.01% | 523,733 | 55.23M |
| 236 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | 1.65% | 2,294,685 | 2.20B |
| 237 | OGN | Organon & Co. | 2.26B | 1.87% | 6,954,883 | 6.22B |
| 238 | MLYS | Mineralys Therapeutics, Inc. | 2.25B | 0.59% | 640,090 | - |
| 239 | ADPT | Adaptive Biotechnologies Corporation | 2.24B | 2.83% | 1,359,759 | 276.98M |
| 240 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.14% | 1,275,310 | 158.18M |
| 241 | DFTX | Definium Therapeutics, Inc. | 2.19B | -1.44% | 1,618,054 | - |
| 242 | SNDX | Syndax Pharmaceuticals, Inc. | 2.15B | 0.74% | 888,035 | 172.35M |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | 0.06% | 1,302,014 | 283.06M |
| 244 | BHC | Bausch Health Companies Inc. | 2.12B | -0.70% | 985,827 | 10.27B |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.12B | 2.31% | 663,369 | 184.42M |
| 246 | NEOG | Neogen Corporation | 2.09B | 5.14% | 2,960,906 | 870.56M |
| 247 | GRAL | GRAIL, Inc. | 2.07B | 5.10% | 558,152 | 147.17M |
| 248 | SEM | Select Medical Holdings Corporation | 2.03B | -0.06% | 968,094 | 5.45B |
| 249 | AHG | Akso Health Group | 2.02B | -4.49% | 155,553 | 14.84M |
| 250 | ANAB | AnaptysBio, Inc. | 2.02B | 2.17% | 486,423 | 234.60M |
| 251 | CAPR | Capricor Therapeutics, Inc. | 2.00B | 0.52% | 950,146 | 11.13M |
| 252 | ZYME | Zymeworks Inc. | 1.99B | 3.10% | 743,568 | 105.97M |
| 253 | WGS | GeneDx Holdings Corp. | 1.96B | 9.64% | 597,388 | 427.54M |
| 254 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | 0.45% | 652,549 | 54.03M |
| 255 | ESTA | Establishment Labs Holdings Inc. | 1.95B | 5.66% | 359,285 | 211.08M |
| 256 | SION | Sionna Therapeutics, Inc. | 1.95B | 3.66% | 900,097 | - |
| 257 | GLPG | Galapagos NV | 1.92B | 1.03% | 176,714 | 1.31B |
| 258 | OCUL | Ocular Therapeutix, Inc. | 1.91B | -1.13% | 2,606,170 | 51.95M |
| 259 | TYRA | Tyra Biosciences, Inc. | 1.90B | -0.98% | 1,415,986 | - |
| 260 | PHVS | Pharvaris N.V. | 1.88B | 2.87% | 134,766 | - |
| 261 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.87B | 2.73% | 880,195 | -665.00K |
| 262 | RXRX | Recursion Pharmaceuticals, Inc. | 1.87B | 3.51% | 9,065,612 | 74.68M |
| 263 | PVLA | Palvella Therapeutics, Inc. | 1.85B | 0.41% | 121,620 | - |
| 264 | MESO | Mesoblast Limited | 1.85B | -0.61% | 238,914 | 65.38M |
| 265 | AORT | Artivion, Inc. | 1.84B | -1.61% | 237,859 | 441.33M |
| 266 | MD | Pediatrix Medical Group, Inc. | 1.83B | 3.67% | 890,991 | 1.91B |
| 267 | TRVI | Trevi Therapeutics, Inc. | 1.80B | 5.33% | 1,434,634 | - |
| 268 | INVA | Innoviva, Inc. | 1.79B | 0.92% | 582,829 | 411.33M |
| 269 | VCEL | Vericel Corporation | 1.79B | 2.03% | 488,930 | 276.26M |
| 270 | AXGN | Axogen, Inc. | 1.79B | 2.96% | 666,670 | 225.21M |
| 271 | NTLA | Intellia Therapeutics, Inc. | 1.75B | 3.65% | 2,986,323 | 67.67M |
| 272 | ATEC | Alphatec Holdings, Inc. | 1.74B | 2.40% | 2,039,256 | 764.16M |
| 273 | AHCO | AdaptHealth Corp. | 1.74B | 3.65% | 1,351,099 | 3.24B |
| 274 | RAPP | Rapport Therapeutics, Inc. | 1.73B | 4.33% | 496,199 | - |
| 275 | HRMY | Harmony Biosciences Holdings, Inc. | 1.69B | 0.83% | 693,095 | 868.45M |
| 276 | ADUS | Addus HomeCare Corporation | 1.69B | -1.96% | 141,875 | 1.42B |
| 277 | NRIX | Nurix Therapeutics, Inc. | 1.69B | 2.45% | 1,279,200 | 71.78M |
| 278 | SGRY | Surgery Partners, Inc. | 1.68B | 0.08% | 754,686 | 3.31B |
| 279 | NUVB | Nuvation Bio Inc. | 1.66B | 3.19% | 2,341,492 | 62.90M |
| 280 | OMCL | Omnicell, Inc. | 1.65B | 3.77% | 431,185 | 1.18B |
| 281 | GENB | Generate Biomedicines, Inc. | 1.64B | 0.70% | 366,092 | 31.89M |
| 282 | INSP | Inspire Medical Systems, Inc. | 1.64B | 3.48% | 908,401 | 911.98M |
| 283 | ANIP | ANI Pharmaceuticals, Inc. | 1.63B | -0.03% | 205,431 | 883.37M |
| 284 | OCS | Oculis Holding AG | 1.63B | 1.62% | 157,864 | 1.51M |
| 285 | DMRA | Damora Therapeutics, Inc. | 1.61B | 1.14% | 325,496 | - |
| 286 | IMCR | Immunocore Holdings plc | 1.61B | 0.70% | 369,712 | 400.02M |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.61B | 3.74% | 692,937 | 336.39M |
| 288 | VIR | Vir Biotechnology, Inc. | 1.61B | 7.95% | 2,698,234 | 68.56M |
| 289 | NBTX | Nanobiotix S.A. | 1.59B | -0.53% | 101,341 | 38.27M |
| 290 | PRGO | Perrigo Company plc | 1.58B | 1.41% | 2,171,362 | 4.25B |
| 291 | BHVN | Biohaven Ltd. | 1.57B | 3.16% | 1,592,400 | - |
| 292 | MBX | MBX Biosciences, Inc. | 1.56B | - | 462,094 | - |
| 293 | VRDN | Viridian Therapeutics, Inc. | 1.55B | 2.64% | 1,719,837 | 70.85M |
| 294 | ARDX | Ardelyx, Inc. | 1.55B | - | 3,737,813 | 407.32M |
| 295 | SVRA | Savara Inc. | 1.54B | 2.53% | 1,265,092 | - |
| 296 | UFPT | UFP Technologies, Inc. | 1.51B | -3.62% | 183,828 | 602.80M |
| 297 | BCAX | Bicara Therapeutics Inc. | 1.50B | 3.79% | 823,622 | - |
| 298 | IOVA | Iovance Biotherapeutics, Inc. | 1.50B | 5.20% | 13,922,189 | 263.50M |
| 299 | ATRC | AtriCure, Inc. | 1.49B | 2.58% | 438,639 | 534.53M |
| 300 | IMTX | Immatics N.V. | 1.47B | 0.69% | 247,507 | 56.67M |
| 301 | TNDM | Tandem Diabetes Care, Inc. | 1.45B | 5.02% | 2,579,246 | 1.01B |
| 302 | ENOV | Enovis Corporation | 1.44B | 0.97% | 505,077 | 2.25B |
| 303 | AVAH | Aveanna Healthcare Holdings Inc. | 1.44B | 3.11% | 1,396,811 | 2.43B |
| 304 | ASTH | Astrana Health, Inc. | 1.44B | 0.66% | 343,406 | 3.18B |
| 305 | OLMA | Olema Pharmaceuticals, Inc. | 1.42B | 2.32% | 794,966 | - |
| 306 | HROW | Harrow, Inc. | 1.41B | 2.16% | 378,174 | 272.30M |
| 307 | PGEN | Precigen, Inc. | 1.41B | -4.56% | 4,185,551 | 9.68M |
| 308 | ATAI | AtaiBeckley Inc. | 1.40B | 1.58% | 3,544,333 | 4.09M |
| 309 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | -0.28% | 754,858 | 123.67M |
| 310 | WVE | Wave Life Sciences Ltd. | 1.39B | 1.79% | 6,266,635 | 42.73M |
| 311 | PRCT | PROCEPT BioRobotics Corporation | 1.39B | 4.82% | 1,045,335 | 308.05M |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.38B | 0.95% | 2,453,668 | 2.50M |
| 313 | PLSE | Pulse Biosciences, Inc. | 1.37B | 6.34% | 272,952 | 350.00K |
| 314 | NVAX | Novavax, Inc. | 1.37B | 3.45% | 3,298,186 | 1.12B |
| 315 | TSHA | Taysha Gene Therapies, Inc. | 1.35B | 6.56% | 2,036,989 | 9.77M |
| 316 | ARDT | Ardent Health, Inc. | 1.35B | 1.62% | 355,527 | 6.32B |
| 317 | MLTX | MoonLake Immunotherapeutics | 1.35B | 1.90% | 1,075,884 | - |
| 318 | DBVT | DBV Technologies S.A. | 1.35B | -2.26% | 311,448 | 5.64M |
| 319 | PGNY | Progyny, Inc. | 1.34B | 1.12% | 2,118,495 | 1.29B |
| 320 | HCSG | Healthcare Services Group, Inc. | 1.34B | -0.83% | 757,141 | 1.84B |
| 321 | NVCR | NovoCure Limited | 1.29B | 5.41% | 931,276 | 655.35M |
| 322 | CRVS | Corvus Pharmaceuticals, Inc. | 1.28B | 0.53% | 1,213,210 | - |
| 323 | ZBIO | Zenas BioPharma, Inc. | 1.27B | 1.43% | 695,393 | 10.00M |
| 324 | PHAR | Pharming Group N.V. | 1.27B | 4.25% | 22,189 | 376.13M |
| 325 | NNNN | Anbio Biotechnology | 1.27B | 1.05% | 35,698 | 8.65M |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.22B | 3.17% | 335,111 | - |
| 327 | INBX | Inhibrx Biosciences, Inc. | 1.22B | 7.40% | 200,362 | 1.30M |
| 328 | STAA | STAAR Surgical Company | 1.21B | -8.98% | 2,059,928 | 239.44M |
| 329 | CNMD | CONMED Corporation | 1.20B | 3.30% | 377,244 | 1.37B |
| 330 | EYPT | EyePoint, Inc. | 1.20B | -1.24% | 598,467 | 31.37M |
| 331 | IRMD | IRADIMED CORPORATION | 1.20B | 0.02% | 82,664 | 83.81M |
| 332 | MPLT | MapLight Therapeutics, Inc. | 1.19B | 2.70% | 163,933 | - |
| 333 | QDEL | QuidelOrtho Corporation | 1.18B | 7.71% | 1,689,849 | 2.73B |
| 334 | USPH | U.S. Physical Therapy, Inc. | 1.17B | -1.54% | 118,643 | 773.34M |
| 335 | COLL | Collegium Pharmaceutical, Inc. | 1.15B | 0.06% | 512,302 | 780.57M |
| 336 | KMTS | Kestra Medical Technologies, Ltd. | 1.15B | 5.22% | 160,276 | 83.72M |
| 337 | AVNS | Avanos Medical, Inc. | 1.15B | 69.51% | 23,937,496 | 701.20M |
| 338 | ABCL | AbCellera Biologics Inc. | 1.14B | 2.73% | 3,196,870 | 75.13M |
| 339 | GERN | Geron Corporation | 1.13B | 2.31% | 17,827,990 | 183.88M |
| 340 | BFLY | Butterfly Network, Inc. | 1.13B | 3.74% | 3,331,717 | 97.61M |
| 341 | EVO | Evotec SE | 1.13B | 12.23% | 110,341 | 925.65M |
| 342 | AZTA | Azenta, Inc. | 1.12B | 3.99% | 1,037,421 | 595.03M |
| 343 | INNV | InnovAge Holding Corp. | 1.11B | 0.37% | 186,994 | 915.37M |
| 344 | ALVO | Alvotech | 1.10B | -4.85% | 274,834 | 588.90M |
| 345 | NEO | NeoGenomics, Inc. | 1.09B | 4.37% | 1,787,483 | 727.33M |
| 346 | SEPN | Septerna, Inc. | 1.08B | 3.38% | 213,430 | 45.95M |
| 347 | PNTG | The Pennant Group, Inc. | 1.07B | -2.14% | 133,179 | 947.71M |
| 348 | CLOV | Clover Health Investments, Corp. | 1.07B | 0.49% | 3,618,847 | 1.92B |
| 349 | QURE | uniQure N.V. | 1.07B | -4.63% | 1,218,982 | 16.10M |
| 350 | ORIC | ORIC Pharmaceuticals, Inc. | 1.06B | 1.25% | 1,013,656 | - |
| 351 | XERS | Xeris Biopharma Holdings, Inc. | 1.05B | 1.68% | 1,138,695 | 291.85M |
| 352 | GHRS | GH Research PLC | 1.04B | 2.82% | 83,234 | - |
| 353 | KALV | KalVista Pharmaceuticals, Inc. | 1.04B | 3.57% | 1,458,854 | 73.62M |
| 354 | URGN | UroGen Pharma Ltd. | 1.03B | 4.64% | 617,477 | 109.79M |
| 355 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | - | 1,043,390 | 175.11M |
| 356 | AKTS | Aktis Oncology, Inc. | 986.12M | 2.88% | 213,276 | 6.50M |
| 357 | IVA | Inventiva S.A. | 982.77M | 9.98% | 1,769,470 | 9.31M |
| 358 | CTMX | CytomX Therapeutics, Inc. | 981.44M | 3.42% | 7,158,406 | 76.20M |
| 359 | CMPX | Compass Therapeutics, Inc. | 979.68M | 4.62% | 3,542,882 | 850.00K |
| 360 | BLFS | BioLife Solutions, Inc. | 979.04M | 0.80% | 323,573 | 96.21M |
| 361 | CRON | Cronos Group Inc. | 977.92M | - | 1,035,498 | 146.59M |
| 362 | SSII | SS Innovations International, Inc. | 977.71M | 2.09% | 116,391 | 42.48M |
| 363 | AMPH | Amphastar Pharmaceuticals, Inc. | 970.01M | 0.09% | 343,450 | 719.89M |
| 364 | PCRX | Pacira BioSciences, Inc. | 961.63M | -1.29% | 307,059 | 726.41M |
| 365 | LMRI | Lumexa Imaging Holdings, Inc. | 960.14M | 3.31% | 625,340 | 1.02B |
| 366 | EVMN | Evommune, Inc. | 959.17M | -1.41% | 303,082 | 13.00M |
| 367 | JBIO | Jade Biosciences, Inc. | 958.71M | 5.14% | 782,252 | - |
| 368 | TDOC | Teladoc Health, Inc. | 945.46M | 0.38% | 3,060,061 | 2.53B |
| 369 | ANNX | Annexon, Inc. | 930.75M | -0.17% | 2,146,582 | - |
| 370 | SANA | Sana Biotechnology, Inc. | 928.70M | 8.41% | 16,411,205 | - |
| 371 | JANX | Janux Therapeutics, Inc. | 927.07M | 2.28% | 758,368 | 10.00M |
| 372 | MGTX | MeiraGTx Holdings plc | 919.53M | 17.24% | 1,209,594 | 81.39M |
| 373 | XNCR | Xencor, Inc. | 917.47M | 3.65% | 806,924 | 125.58M |
| 374 | CDNA | CareDx, Inc. | 902.94M | 4.75% | 606,872 | 379.81M |
| 375 | FTRE | Fortrea Holdings Inc. | 896.67M | 2.24% | 600,262 | 2.72B |
| 376 | INMD | InMode Ltd. | 895.89M | 1.07% | 779,700 | 370.50M |
| 377 | CERT | Certara, Inc. | 892.35M | 0.52% | 2,222,346 | 418.84M |
| 378 | OPK | OPKO Health, Inc. | 888.11M | - | 1,593,423 | 606.88M |
| 379 | SDGR | Schrödinger, Inc. | 879.26M | 4.02% | 1,603,158 | 255.87M |
| 380 | DRUG | Bright Minds Biosciences Inc. | 874.86M | 4.65% | 99,064 | - |
| 381 | SLS | SELLAS Life Sciences Group, Inc. | 872.77M | 2.10% | 3,390,886 | - |
| 382 | CGEM | Cullinan Therapeutics, Inc. | 868.55M | 0.70% | 889,598 | - |
| 383 | TALK | Talkspace, Inc. | 863.78M | -0.19% | 1,002,954 | 228.87M |
| 384 | IART | Integra LifeSciences Holdings Corporation | 861.99M | 8.01% | 926,544 | 1.64B |
| 385 | VOR | Vor Biopharma Inc. | 859.93M | -0.63% | 1,165,759 | - |
| 386 | TBPH | Theravance Biopharma, Inc. | 854.78M | 0.61% | 489,233 | 107.46M |
| 387 | OMER | Omeros Corporation | 852.43M | 4.04% | 777,267 | - |
| 388 | ABUS | Arbutus Biopharma Corporation | 850.33M | -0.46% | 1,360,365 | 14.08M |
| 389 | MNKD | MannKind Corporation | 846.10M | 3.79% | 3,566,587 | 348.97M |
| 390 | MRVI | Maravai LifeSciences Holdings, Inc. | 843.18M | 7.19% | 3,587,480 | 185.74M |
| 391 | ANRO | Alto Neuroscience, Inc. | 824.83M | 0.27% | 534,282 | - |
| 392 | BVS | Bioventus Inc. | 824.06M | 5.20% | 592,749 | 568.09M |
| 393 | SGP | SpyGlass Pharma, Inc. | 819.62M | 2.72% | 90,279 | - |
| 394 | SLDB | Solid Biosciences Inc. | 809.76M | -1.91% | 1,586,975 | - |
| 395 | SPRY | ARS Pharmaceuticals, Inc. | 808.28M | 1.75% | 836,251 | 84.28M |
| 396 | KURA | Kura Oncology, Inc. | 807.33M | 4.82% | 1,703,671 | 67.48M |
| 397 | TLRY | Tilray Brands, Inc. | 803.13M | 2.83% | 2,614,997 | 858.28M |
| 398 | FBRX | Forte Biosciences, Inc. | 793.58M | 5.95% | 292,283 | - |
| 399 | DSGN | Design Therapeutics, Inc. | 779.54M | 2.27% | 311,396 | - |
| 400 | GDRX | GoodRx Holdings, Inc. | 763.94M | 3.72% | 1,117,566 | 796.85M |
| 401 | RLMD | Relmada Therapeutics, Inc. | 754.15M | -2.57% | 1,427,594 | - |
| 402 | NUTX | Nutex Health Inc. | 751.47M | 1.48% | 158,373 | 875.26M |
| 403 | TENX | Tenax Therapeutics, Inc. | 743.44M | 1.93% | 634,058 | - |
| 404 | LXRX | Lexicon Pharmaceuticals, Inc. | 741.44M | 2.34% | 1,255,761 | 49.80M |
| 405 | CMPS | COMPASS Pathways plc | 741.31M | -0.35% | 1,771,554 | - |
| 406 | ETON | Eton Pharmaceuticals, Inc. | 739.96M | 4.11% | 269,536 | 79.95M |
| 407 | CSTL | Castle Biosciences, Inc. | 738.31M | 3.57% | 210,987 | 344.23M |
| 408 | CBLL | CeriBell, Inc. | 735.89M | 1.99% | 347,616 | 89.06M |
| 409 | BIOA | BioAge Labs, Inc. | 735.37M | 2.35% | 326,056 | 9.00M |
| 410 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 734.70M | 2.57% | 584,298 | - |
| 411 | OMDA | Omada Health, Inc. | 734.21M | 2.81% | 640,680 | 260.21M |
| 412 | AMN | AMN Healthcare Services, Inc. | 725.96M | 1.08% | 483,097 | 2.73B |
| 413 | GYRE | Gyre Therapeutics, Inc. | 715.90M | 1.95% | 36,473 | 116.59M |
| 414 | EHAB | Enhabit, Inc. | 707.08M | -0.29% | 1,067,305 | 1.06B |
| 415 | ARVN | Arvinas, Inc. | 703.57M | 3.97% | 841,321 | 262.60M |
| 416 | PSNL | Personalis, Inc. | 699.25M | 5.86% | 999,321 | 69.65M |
| 417 | DRTS | Alpha Tau Medical Ltd. | 689.12M | 2.49% | 454,196 | - |
| 418 | LBRX | LB Pharmaceuticals Inc | 672.20M | 4.48% | 302,314 | - |
| 419 | IRWD | Ironwood Pharmaceuticals, Inc. | 658.76M | 10.68% | 3,613,370 | 296.15M |
| 420 | PRME | Prime Medicine, Inc. | 655.19M | 1.09% | 2,443,337 | 4.63M |
| 421 | CBIO | Crescent Biopharma, Inc. | 648.34M | 8.50% | 592,109 | 10.84M |
| 422 | SIBN | SI-BONE, Inc. | 637.31M | 3.07% | 656,990 | 200.93M |
| 423 | OCGN | Ocugen, Inc. | 608.22M | 0.56% | 4,591,079 | 4.41M |
| 424 | BWAY | BrainsWay Ltd. | 597.61M | 4.03% | 132,256 | 52.23M |
| 425 | HSTM | HealthStream, Inc. | 597.11M | -0.15% | 189,825 | 304.06M |
| 426 | CTKB | Cytek Biosciences, Inc. | 593.90M | 0.65% | 517,382 | 201.49M |
| 427 | AVR | Anteris Technologies Global Corp. | 586.48M | 1.45% | 770,130 | 1.91M |
| 428 | MDXG | MiMedx Group, Inc. | 582.38M | - | 1,194,950 | 418.63M |
| 429 | RIGL | Rigel Pharmaceuticals, Inc. | 579.87M | 4.74% | 414,112 | 294.28M |
| 430 | ANL | Adlai Nortye Ltd. | 578.60M | 30.02% | 1,085,928 | 5.40M |
| 431 | CRMD | CorMedix Inc. | 577.07M | -0.27% | 1,164,629 | 311.71M |
| 432 | PROK | ProKidney Corp. | 576.66M | -2.05% | 1,619,637 | 893.00K |
| 433 | ZVRA | Zevra Therapeutics, Inc. | 574.79M | 0.72% | 598,134 | 106.47M |
| 434 | EIKN | Eikon Therapeutics, Inc. | 574.41M | 7.50% | 440,818 | - |
| 435 | PRTA | Prothena Corporation plc | 571.17M | 2.91% | 370,923 | 9.68M |
| 436 | TCMD | Tactile Systems Technology, Inc. | 570.13M | 3.38% | 393,149 | 329.52M |
| 437 | KYTX | Kyverna Therapeutics, Inc. | 565.86M | -1.37% | 536,756 | - |
| 438 | UPB | Upstream Bio, Inc. | 562.70M | 1.08% | 645,990 | 2.85M |
| 439 | TECX | Tectonic Therapeutic, Inc. | 562.36M | -0.03% | 198,720 | - |
| 440 | EMBC | Embecta Corp. | 560.22M | 2.16% | 693,284 | 1.08B |
| 441 | ALLO | Allogene Therapeutics, Inc. | 555.81M | -25.49% | 42,304,967 | 22.00K |
| 442 | LYEL | Lyell Immunopharma, Inc. | 545.18M | -5.77% | 130,853 | 36.00K |
| 443 | ACRS | Aclaris Therapeutics, Inc. | 544.86M | 0.51% | 2,684,257 | 7.83M |
| 444 | ZURA | Zura Bio Limited | 542.72M | 0.70% | 657,635 | - |
| 445 | VALN | Valneva SE | 542.07M | -0.65% | 91,455 | 205.07M |
| 446 | VSTM | Verastem, Inc. | 539.31M | 8.48% | 3,515,752 | 30.91M |
| 447 | ESPR | Esperion Therapeutics, Inc. | 526.46M | -7.66% | 7,915,687 | 403.14M |
| 448 | BBNX | Beta Bionics, Inc. | 526.27M | 11.10% | 1,204,064 | 100.25M |
| 449 | FULC | Fulcrum Therapeutics, Inc. | 526.14M | 2.20% | 1,036,048 | 80.00M |
| 450 | PHR | Phreesia, Inc. | 522.56M | 0.47% | 1,498,655 | 480.59M |
| 451 | IMMX | Immix Biopharma, Inc. | 522.17M | 1.65% | 519,894 | - |
| 452 | NPCE | NeuroPace, Inc. | 516.79M | 3.16% | 129,552 | 99.99M |
| 453 | STTK | Shattuck Labs, Inc. | 512.44M | 0.15% | 330,522 | 1.00M |
| 454 | OFIX | Orthofix Medical Inc. | 510.64M | 0.55% | 191,496 | 822.31M |
| 455 | AGMB | AgomAb Therapeutics NV | 510.27M | 0.48% | 229,906 | - |
| 456 | ENGN | enGene Therapeutics Inc. | 509.12M | 2.29% | 140,825 | - |
| 457 | AQST | Aquestive Therapeutics, Inc. | 506.49M | -0.95% | 1,200,756 | 44.55M |
| 458 | LRMR | Larimar Therapeutics, Inc. | 505.91M | 0.21% | 1,114,199 | - |
| 459 | TRDA | Entrada Therapeutics, Inc. | 505.08M | 1.01% | 89,461 | 25.42M |
| 460 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 461 | LXEO | Lexeo Therapeutics, Inc. | 494.16M | 4.55% | 880,039 | - |
| 462 | FDMT | 4D Molecular Therapeutics, Inc. | 493.16M | -3.78% | 1,052,341 | 85.21M |
| 463 | VREX | Varex Imaging Corporation | 492.13M | 2.80% | 296,403 | 854.40M |
| 464 | ADCT | ADC Therapeutics SA | 490.39M | 1.31% | 542,053 | 81.36M |
| 465 | KMDA | Kamada Ltd. | 489.31M | -0.24% | 37,066 | 180.46M |
| 466 | CTNM | Contineum Therapeutics, Inc. | 484.25M | 1.65% | 186,828 | - |
| 467 | CATX | Perspective Therapeutics, Inc. | 484.22M | -2.30% | 976,869 | 884.00K |
| 468 | ABSI | Absci Corporation | 482.02M | 3.28% | 3,220,557 | 2.80M |
| 469 | RGNX | REGENXBIO Inc. | 480.04M | 2.88% | 577,710 | 170.44M |
| 470 | STRO | Sutro Biopharma, Inc. | 476.81M | 9.89% | 509,710 | 102.48M |
| 471 | VTVT | vTv Therapeutics Inc. | 475.66M | 3.32% | 18,409 | 17.00K |
| 472 | PACB | Pacific Biosciences of California, Inc. | 474.14M | 8.28% | 6,339,459 | 160.01M |
| 473 | ARMP | Armata Pharmaceuticals, Inc. | 471.83M | 10.18% | 41,733 | 4.90M |
| 474 | XOMA | XOMA Royalty Corporation | 469.60M | 1.82% | 138,168 | 52.15M |
| 475 | ASMB | Assembly Biosciences, Inc. | 467.00M | 0.68% | 81,143 | 72.30M |
| 476 | AVIR | Atea Pharmaceuticals, Inc. | 462.10M | 1.58% | 238,430 | - |
| 477 | FLGT | Fulgent Genetics, Inc. | 462.09M | 4.71% | 508,803 | 322.67M |
| 478 | MYGN | Myriad Genetics, Inc. | 459.13M | 6.97% | 1,028,006 | 824.50M |
| 479 | IVVD | Invivyd, Inc. | 455.31M | -6.40% | 2,501,402 | 53.43M |
| 480 | AURA | Aura Biosciences, Inc. | 454.83M | 2.60% | 301,400 | - |
| 481 | BNTC | Benitec Biopharma Inc. | 453.88M | 10.42% | 136,184 | - |
| 482 | KIDS | OrthoPediatrics Corp. | 451.48M | 5.37% | 228,797 | 236.35M |
| 483 | DNA | Ginkgo Bioworks Holdings, Inc. | 449.36M | 15.57% | 2,016,576 | 170.16M |
| 484 | EPRX | Eupraxia Pharmaceuticals Inc. | 447.41M | 0.56% | 132,158 | - |
| 485 | EBS | Emergent BioSolutions Inc. | 447.24M | 5.10% | 800,599 | 742.90M |
| 486 | ANGO | AngioDynamics, Inc. | 436.41M | 2.25% | 773,472 | 313.73M |
| 487 | PRTC | PureTech Health plc | 434.01M | 0.34% | 7,330 | 6.39M |
| 488 | VNDA | Vanda Pharmaceuticals Inc. | 432.67M | 2.23% | 1,123,137 | 216.11M |
| 489 | ALT | Altimmune, Inc. | 428.05M | 1.86% | 1,990,993 | 41.00K |
| 490 | IPSC | Century Therapeutics, Inc. | 425.94M | 4.41% | 1,857,664 | 109.16M |
| 491 | ENTA | Enanta Pharmaceuticals, Inc. | 424.55M | 2.52% | 111,170 | 66.98M |
| 492 | CLYM | Climb Bio, Inc. | 422.75M | 2.55% | 433,781 | - |
| 493 | AKBA | Akebia Therapeutics, Inc. | 417.89M | 6.12% | 2,259,198 | 236.20M |
| 494 | CGC | Canopy Growth Corporation | 412.36M | 0.93% | 11,360,124 | 203.04M |
| 495 | AUNA | Auna S.A. | 411.51M | -3.14% | 371,237 | 1.30B |
| 496 | CYH | Community Health Systems, Inc. | 410.97M | 0.33% | 978,852 | 12.49B |
| 497 | YDES | YD Bio Limited | 400.82M | -2.44% | 40,695 | 510.36K |
| 498 | RCKT | Rocket Pharmaceuticals, Inc. | 397.21M | - | 2,430,530 | - |
| 499 | LCTX | Lineage Cell Therapeutics, Inc. | 396.05M | 5.30% | 763,763 | 14.56M |
| 500 | IRD | Opus Genetics, Inc. | 394.88M | -0.36% | 397,922 | 14.20M |